Obama health reform plan slaps drugmakers
Drugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals
with generic competitor.
Eli Lilly and Co.
Articles
Lilly, Merck, Pfizer starting research center
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
WellPoint gets tax delay in Obama health plan
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
Teva gets European OK to sell generic of Lilly’s Evista
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
Lilly asks shareholders to lower takeover barrier
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
Lilly settles Arkansas Zyprexa suit for $18.5M
Arkansas Attorney General Dustin McDaniel on Tuesday announced an $18.5 million settlement of a lawsuit with Eli Lilly &
Co. over off-label marketing of the anti-psychotic drug Zyprexa.
Pfizer’s Viagra patent partially rejected in Lilly fight
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn’t different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.
Lilly awards pay increases to top executives
Eli Lilly and Co. CEO John Lechleiter’s total compensation increased $4.1 million in 2009.
Mississippi settles Zyprexa suit against Lilly for over $18M
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims
the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
Indy without Lilly, the 500?
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
Q&A: Dr. Kristine Courtney
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes
how and why the company spent two years making its clinics some of the first to electronically swap patient records with
a local hospital database.
Lilly shares trade down after fourth-quarter profits falls
Analysts worry about dive in already paltry sales of new blood thinner Effient
Lilly’s profits fall, miss analyst expectations
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
Lilly looks to autoimmune drugs
Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.
Lilly shares get boost from OK of rival’s drug
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators’
clearance of a similar drug.
Biotech firm plans $28M Greenwood plant
Greenwood pharmaceutical firm Elona Biotechnologies plans to build a $28 million production facility and create 70 jobs to
help develop a cheaper form of insulin that could gain significant market share.
FDA letters scold Lilly, others over marketing materials
The letter to Indianapolis-based Lilly cites a print advertisement for the antidepressant Cymbalta that did not adequately
display information about the drug’s side effects.
FDA cancels meeting to review Lilly’s Cymbalta
The agency said the meeting was canceled “to allow time for the FDA to review new information” about a proposed new use for
the drug.
Ruth Lilly remembered for ‘selfless’ giving
Lilly, 94, who died Wednesday, gave away hundreds of millions of dollars of her fortune during her lifetime.
Eli Lilly and Co. heiress Ruth Lilly dies at 94
Over the course of her life, the last surviving great-grandchild of pharmaceutical magnate Eli Lilly gave away much of her
inheritance.